Table 1.
Without defined SLNB status | |||||||
---|---|---|---|---|---|---|---|
Type of metastases (AJCC criteria) | |||||||
Author | Year | Total patients with axillary staging | Patients submitted SNL | ITC | Micro | Macro | SNLB positivity (%) |
Cox | 2001 | 15 | 15 | NS | NS | NS | 3 (20) |
Camp | 2005 | 13 | 13 | NS | NS | NS | 2 (15) |
Wilkie | 2005 | 51 | 51 | 5 | NS | NS | 7 (14) |
Tunon-de-Lara | 2008 | 45 | 45 | 0 | NS | NS | 2 (5) |
Fortunato | 2008 | 77 | 77 | NS | NS | NS | 6 (8) |
Vieira | 2010 | 17 | 14 | NS | NS | NS | 1 (6) |
Parikh | 2012 | 46 | 4 | NS | NS | NS | 1 (2) |
Without defined SLNB status | |||||||
---|---|---|---|---|---|---|---|
Type of metastases (AJCC criteria) | |||||||
Author | Year | Total patients with axillary staging | Patients submitted SNL | ITC | Micro | Macro | SNLB positivity (%) |
Zavotsky | 1999 | 14 | 14 | 1 | 0 | 1 | 2 (14) |
Klauber-DeMore | 2000 | 31 | 31 | 0 | 2 | 1 | 3 (10) |
Intra | 2003 | 41 | 41 | 0 | 2 | 2 | 4 (10) |
Katz | 2006 | 21 | 21 | 0 | 1 | 1 | 2(10) |
Leidenius | 2006 | 11 | 11 | 1 | 0 | 0 | 1 (9) |
Zavagno | 2007 | 43 | 43 | 0 | 1 | 3 | 4 (9) |
Gray | 2007 | 79 | 77 | 2 | 2 | 2 | 6 (7) |
Guth | 2008 | 44 | 20 | 2 | 0 | 3 | 5 (11) |
Sakr | 2008 | 20 | 20 | 0 | 2 | 0 | 2 (10) |
Lyons | 2012 | 112 | 112 | 6 | 5 | 3 | 14 (12) |
Ko | 2012 | 293 | 180 | 6 | 12 | 4 | 22 (8) |
Kapoor | 2013 | 45 | 31 | 4 | 4 | 1 | 9 (20) |
Margalit | 2013 | 68 | 53 | 4 | 3 | 0 | 7 (10) |
Matsen | 2014 | 414 | 414 | 0 | 26 | 6 | 32 (7,7) |
Hanna | 2014 | 81 | 64 | 2 | 0 | 0 | 2 (3) |
Orzalesi | 2016 | 126 | 126 | 10 | 3 | 5 | 18 (14,3) |
AJCC, American Joint Committee on Cancer; SNL, sentinel lymph node; ITC, isolated tumour cells; Micro, micrometastases; Macro, macrometastases